Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference
Gain Therapeutics announced that President and CEO Gene Mack will participate in one-on-one meetings at the H.C. Wainwright 28th Annual Global Investment Conference in New York City from September 14-16. An on-demand company presentation will be available starting September 11, 2026, at 7:00 a.m. ET, with the replay accessible for 90 days on the company's website.
Key figures
- Drug Name
- rexaceract
- Phase Of Trial
- Phase 1b
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.